Key pointsr Magnesium sulphate is the recommended treatment for pre-eclampsia and is now widely recommended for perinatal neuroprotection.r MgSO 4 has vasodilatory and negative inotropic effects; however, it is unknown whether it impairs the cardiovascular and cerebrovascular adaptations to acute asphyxia in preterm fetuses.r Intravenous infusion of a clinically comparable dose of MgSO 4 to the preterm fetus was associated with no change in blood pressure, reduced fetal heart rate and increased femoral arterial conductance and blood flow; femoral arterial waveform height and width were increased, consistent with increased stroke volume during MgSO 4 infusion.r During asphyxia MgSO 4 was associated with increased carotid and femoral arterial conductance and blood flows; after asphyxia, fetal heart rate was lower and carotid and femoral blood flows and vascular conductance were greater in MgSO 4 -treated fetuses.r These data demonstrate that MgSO 4 may increase perfusion of peripheral vascular beds during adverse perinatal events such as asphyxia.Abstract Magnesium sulphate is a standard therapy for eclampsia in pregnancy and is widely recommended for perinatal neuroprotection during threatened preterm labour. MgSO 4 is a vasodilator and negative inotrope. Therefore the aim of this study was to investigate the effect of MgSO 4 on the cardiovascular and cerebrovascular responses of the preterm fetus to asphyxia. Fetal sheep were instrumented at 98 ± 1 days of gestation (term = 147 days). At 104 days, unanaesthetised fetuses were randomly assigned to receive an intravenous infusion of MgSO 4 (n = 6) or saline (n = 9). At 105 days all fetuses underwent umbilical cord occlusion for 25 min. Before occlusion, MgSO 4 treatment reduced heart rate and increased femoral blood flow (FBF) and vascular conductance compared to controls. During occlusion, carotid and femoral arterial conductance and blood flows were higher in MgSO 4 -treated fetuses than controls. After occlusion, fetal heart rate was lower and carotid and femoral arterial conductance and blood flows were higher in MgSO 4 -treated fetuses than controls. Femoral arterial waveform height and width were increased during MgSO 4 infusion, consistent with increased stroke volume. MgSO 4 did not alter the fetal neurophysiological or nuchal electromyographic responses to asphyxia. These data demonstrate that a clinically comparable dose of MgSO 4 increased FBF and stroke volume without impairing mean arterial pressure (MAP) or carotid blood flow (CaBF) during and immediately after profound asphyxia. Thus, MgSO 4 may increase perfusion of peripheral vascular beds during adverse perinatal events.